Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Medical | 3 | 2022 | 96 | 1.460 |
Why?
|
| Hematologic Diseases | 1 | 2022 | 11 | 0.780 |
Why?
|
| Self-Directed Learning as Topic | 1 | 2020 | 3 | 0.710 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 60 | 0.660 |
Why?
|
| Faculty, Medical | 2 | 2019 | 54 | 0.550 |
Why?
|
| Xenopus laevis | 2 | 2010 | 50 | 0.540 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2010 | 90 | 0.510 |
Why?
|
| Biomedical Research | 1 | 2016 | 97 | 0.490 |
Why?
|
| Education, Medical, Graduate | 3 | 2019 | 108 | 0.410 |
Why?
|
| Curriculum | 4 | 2022 | 291 | 0.380 |
Why?
|
| Metamorphosis, Biological | 1 | 2010 | 10 | 0.330 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 25 | 0.330 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2010 | 126 | 0.300 |
Why?
|
| Rod Opsins | 2 | 2010 | 14 | 0.290 |
Why?
|
| Pediatrics | 2 | 2019 | 92 | 0.270 |
Why?
|
| Program Development | 2 | 2020 | 77 | 0.210 |
Why?
|
| Laboratories | 1 | 2022 | 18 | 0.190 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2022 | 17 | 0.190 |
Why?
|
| Program Evaluation | 1 | 2020 | 167 | 0.170 |
Why?
|
| Feasibility Studies | 1 | 2020 | 193 | 0.160 |
Why?
|
| Health Personnel | 1 | 2020 | 95 | 0.160 |
Why?
|
| Competency-Based Education | 1 | 2019 | 17 | 0.150 |
Why?
|
| Staff Development | 1 | 2018 | 8 | 0.150 |
Why?
|
| Humans | 8 | 2022 | 28121 | 0.150 |
Why?
|
| Mentoring | 1 | 2018 | 12 | 0.150 |
Why?
|
| Education, Medical, Continuing | 1 | 2018 | 34 | 0.140 |
Why?
|
| Genetic Counseling | 1 | 2017 | 14 | 0.140 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 969 | 0.130 |
Why?
|
| Bone Resorption | 1 | 1996 | 23 | 0.130 |
Why?
|
| Superoxides | 1 | 1996 | 61 | 0.130 |
Why?
|
| NADPH Oxidases | 1 | 1996 | 69 | 0.130 |
Why?
|
| Osteoclasts | 1 | 1996 | 29 | 0.130 |
Why?
|
| Skull | 1 | 1996 | 40 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 143 | 0.120 |
Why?
|
| Education, Medical | 1 | 2016 | 66 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2010 | 656 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 54 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 326 | 0.080 |
Why?
|
| Interprofessional Relations | 2 | 2018 | 66 | 0.070 |
Why?
|
| Animals | 4 | 2010 | 10399 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2006 | 77 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2006 | 206 | 0.070 |
Why?
|
| Ischemic Preconditioning | 1 | 2006 | 4 | 0.070 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2006 | 15 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2019 | 229 | 0.070 |
Why?
|
| Retinal Vessels | 1 | 2006 | 72 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2006 | 245 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 689 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 1050 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2006 | 252 | 0.060 |
Why?
|
| Gene Amplification | 1 | 2003 | 22 | 0.050 |
Why?
|
| COS Cells | 1 | 2003 | 49 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 50 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2003 | 131 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 123 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 276 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 97 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 268 | 0.050 |
Why?
|
| Base Sequence | 1 | 2003 | 584 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 369 | 0.050 |
Why?
|
| Gene Expression | 1 | 2003 | 414 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 329 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 31 | 0.040 |
Why?
|
| Grounded Theory | 1 | 2018 | 13 | 0.040 |
Why?
|
| Mentors | 1 | 2018 | 39 | 0.040 |
Why?
|
| Professionalism | 1 | 2018 | 7 | 0.040 |
Why?
|
| Focus Groups | 1 | 2018 | 95 | 0.040 |
Why?
|
| Physician's Role | 1 | 2018 | 29 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2018 | 156 | 0.040 |
Why?
|
| Teaching | 1 | 2018 | 83 | 0.030 |
Why?
|
| Learning | 1 | 2018 | 97 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 191 | 0.030 |
Why?
|
| Career Choice | 1 | 2017 | 53 | 0.030 |
Why?
|
| Onium Compounds | 1 | 1996 | 8 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 1996 | 22 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 1996 | 107 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2019 | 239 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1014 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 1996 | 1570 | 0.020 |
Why?
|
| Peptide Synthases | 1 | 2006 | 4 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2006 | 9 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2006 | 26 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 17 | 0.020 |
Why?
|
| Autophagy-Related Proteins | 1 | 2006 | 9 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2006 | 35 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 47 | 0.020 |
Why?
|
| Genome | 1 | 2006 | 57 | 0.020 |
Why?
|
| Mice | 1 | 1996 | 4645 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 136 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 198 | 0.020 |
Why?
|
| Ischemia | 1 | 2006 | 84 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 273 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 413 | 0.020 |
Why?
|
| Rats | 1 | 2006 | 1564 | 0.010 |
Why?
|
| Male | 1 | 2017 | 13487 | 0.010 |
Why?
|
| Female | 1 | 2017 | 15156 | 0.010 |
Why?
|